Paul Conyngham used AI to pinpoint the mutations in his dog Rose's tumor — and used the data to have a treatment made just ...
Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines ...
The UW Medicine Cancer Vaccine Institute is also developing vaccines that target breast, ovarian and lung cancers.
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
In early 2026, Moderna reported encouraging long-term data for its personalized cancer vaccine mRNA-4157 (V940) in high-risk melanoma, while the FDA granted expedited review and an August 5, 2026 ...
One dog, one vaccine, one data point. The story of Rosie is fascinating – but it is not yet evidence that AI can beat cancer.
"The vaccine pushed back about 75 percent of the cancer," the dog owner, tech entrepreneur Paul Conyngham, said.
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are spending billions to bring the same technology to human patients.
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results